PL373692A1 - Kompozycja farmaceutyczna zawierająca inhibitory lipazy i glukomannan - Google Patents

Kompozycja farmaceutyczna zawierająca inhibitory lipazy i glukomannan

Info

Publication number: PL373692A1
Authority: PL; Poland
Prior art keywords: glucomannan; pharmaceutical composition; lipase inhibitor; lipase; inhibitor
Prior art date: 2002-04-26

Application number

PL03373692A

Other languages

English (en)

Other versions

PL216022B1 (pl

Inventor

Jacques Bailly

Rainer Eugen Martin

Susanne Raab

Original Assignee

F.Hoffmann-La Roche Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-26

Filing date

2003-04-15

Publication date

2005-09-05

2003-04-15 Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag

2005-09-05 Publication of PL373692A1 publication Critical patent/PL373692A1/pl

2014-02-28 Publication of PL216022B1 publication Critical patent/PL216022B1/pl

Links

LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 title 1
229920002581 Glucomannan Polymers 0.000 title 1
229940086609 Lipase inhibitor Drugs 0.000 title 1
229940046240 glucomannan Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Mycology (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Botany (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medical Informatics (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

PL373692A 2002-04-26 2003-04-15 Kompozycja farmaceutyczna, sposób jej wytwarzania i jej zastosowanie, zestaw do leczenia otylosci, inhibitor lipazy w postaci orlistatu i glukomannan lub konjac, zastosowanie inhibitora lipazy w postaci orlistatu oraz zastosowanie glukomannanu lub konjacu PL216022B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02009254		2002-04-26

Publications (2)

Publication Number	Publication Date
PL373692A1 true PL373692A1 (pl)	2005-09-05
PL216022B1 PL216022B1 (pl)	2014-02-28

Family

ID=29265897

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL373692A PL216022B1 (pl)	2002-04-26	2003-04-15	Kompozycja farmaceutyczna, sposób jej wytwarzania i jej zastosowanie, zestaw do leczenia otylosci, inhibitor lipazy w postaci orlistatu i glukomannan lub konjac, zastosowanie inhibitora lipazy w postaci orlistatu oraz zastosowanie glukomannanu lub konjacu

Country Status (20)

Country	Link
US (2)	US20040033983A1 (pl)
EP (1)	EP1501498B1 (pl)
JP (1)	JP4234017B2 (pl)
KR (1)	KR100625399B1 (pl)
CN (1)	CN1325050C (pl)
AR (1)	AR039664A1 (pl)
AT (1)	ATE453390T1 (pl)
AU (1)	AU2003222814B2 (pl)
BR (1)	BRPI0309406B1 (pl)
CA (1)	CA2483002C (pl)
DE (1)	DE60330764D1 (pl)
ES (1)	ES2335876T3 (pl)
GT (1)	GT200300094A (pl)
MX (1)	MXPA04010371A (pl)
PA (1)	PA8571901A1 (pl)
PE (1)	PE20040596A1 (pl)
PL (1)	PL216022B1 (pl)
RU (1)	RU2297221C2 (pl)
TW (1)	TW200404536A (pl)
WO (1)	WO2003090742A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1781265B1 (en) *	2004-08-25	2010-04-07	Essentialis, Inc.	Pharmaceutical formulations of potassium atp channel openers and uses thereof
ITMI20050010A1 (it) *	2005-01-05	2006-07-06	Aboca S P A	Composizioni farmaceutiche nutraceutiche dietetiche nutrizionali a base di fibre vegetali
KR101252635B1 (ko)	2006-04-20	2013-04-10	(주)아모레퍼시픽	리파아제 저해제 및 친유성 오일흡수제를 포함하는 약학조성물 및 이로부터 제조된 경구 투여용 제제
GB0618725D0 (en) *	2006-09-23	2006-11-01	Jagotec Ag	Composition containing inhibitors of gastro-intestinal lipase
FR2918567B1 (fr) *	2007-07-11	2012-08-03	Pf Medicament	Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
ATE477820T1 (de) *	2007-09-12	2010-09-15	Mader S R L	Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten
US20120053172A1 (en)	2009-02-12	2012-03-01	Cooperatieve Mirzorg U.A.	Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
BRPI0901602B8 (pt) *	2009-04-03	2021-05-25	Ems S/A	formulação farmacêuticas
US9034342B2 (en) *	2010-03-25	2015-05-19	Gateway Health Alliances, Inc	Methods and compositions to reduce fat gain, promote weight loss in animals
WO2012070702A1 (ko) *	2010-11-25	2012-05-31	주식회사 삼양사	올리스태트 및 키토산 함유 조성물 및 그 제조방법
US10507194B2 (en)	2015-08-10	2019-12-17	Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College	Methods for treating obesity
CN108524495B (zh) *	2018-07-10	2019-02-26	中山万汉制药有限公司	奥利司他在制备治疗便秘的药物中的用途
NL2022615B1 (en)	2019-02-21	2020-08-31	Patrick Alexander Unger	Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight
CN115737672A (zh) *	2020-06-01	2023-03-07	山东新时代药业有限公司	一种益生菌和益生元的组合物及其应用
EP4392044A4 (en) *	2021-09-09	2025-01-22	Junion Labs Pte. Ltd.	SUPERABSORBENT HYDROGELS WITH LIPASE INHIBITOR

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4582714A (en) *	1982-07-08	1986-04-15	Mars G.B. Limited	Air or oil emulsion food product having glucomannas as sole stabilizer-thickener
CA1247547A (en) *	1983-06-22	1988-12-28	Paul Hadvary	Leucine derivatives
US5477953A (en) *	1992-03-16	1995-12-26	Environmental Products Corporation	Filter and filter cleaning system for a reverse vending machine
CA2098167C (en)	1992-06-24	2006-12-19	Dorothea Isler	Foodstuffs and feedstuffs containing a lipase inhibitor
JP2628231B2 (ja) *	1992-12-30	1997-07-09	エフエムシーコーポレーション	放出調整賦形剤として容易に入手できるコンニャクグルコマンナン
WO1998033395A1 (fr) *	1997-02-03	1998-08-06	Takahisa Shiota	Aliment prepare a partir d'un sol de farine de konjak
US6004996A (en) *	1997-02-05	1999-12-21	Hoffman-La Roche Inc.	Tetrahydrolipstatin containing compositions
US5942500A (en) *	1998-04-27	1999-08-24	Perry; Stephen C.	Dietary composition to reduce dietary fats
US6093439A (en) *	1998-05-08	2000-07-25	National Starch And Chemical Investment Holding Corporation	Hydrocolloid composition for use as a gelling agent viscosifier and stabilizer
WO2000009122A1 (en) *	1998-08-14	2000-02-24	F. Hoffmann-La Roche Ag	Pharmaceutical compositions containing lipase inhibitors
AU759388B2 (en) *	1998-08-14	2003-04-10	Cheplapharm Arzneimittel Gmbh	Pharmaceutical compositions containing lipase inhibitors and chitosan
YU96602A (sh) *	2000-06-27	2005-03-15	F.Hoffmann-La Roche Ag.	Postupak za spravljanje smeše
PT1307264E (pt)	2000-07-28	2005-02-28	Hoffmann La Roche	Nova composicao farmaceutica
AU2002232575A1 (en) *	2000-12-15	2002-06-24	Pacifichealth Laboratories, Inc.	Nutritional composition for improving the efficacy of a lipase inhibitor
JP2004111852A (ja) *	2002-09-20	2004-04-08	Fujitsu Ltd	半導体装置及びその製造方法

2003
- 2003-04-15 WO PCT/EP2003/003908 patent/WO2003090742A1/en not_active Ceased
- 2003-04-15 BR BRPI0309406A patent/BRPI0309406B1/pt not_active IP Right Cessation
- 2003-04-15 DE DE60330764T patent/DE60330764D1/de not_active Expired - Lifetime
- 2003-04-15 RU RU2004134573/15A patent/RU2297221C2/ru active
- 2003-04-15 JP JP2003587376A patent/JP4234017B2/ja not_active Expired - Fee Related
- 2003-04-15 AT AT03718758T patent/ATE453390T1/de active
- 2003-04-15 CN CNB038093685A patent/CN1325050C/zh not_active Expired - Lifetime
- 2003-04-15 EP EP03718758A patent/EP1501498B1/en not_active Expired - Lifetime
- 2003-04-15 ES ES03718758T patent/ES2335876T3/es not_active Expired - Lifetime
- 2003-04-15 PL PL373692A patent/PL216022B1/pl unknown
- 2003-04-15 KR KR1020047017174A patent/KR100625399B1/ko not_active Expired - Lifetime
- 2003-04-15 CA CA2483002A patent/CA2483002C/en not_active Expired - Lifetime
- 2003-04-15 MX MXPA04010371A patent/MXPA04010371A/es active IP Right Grant
- 2003-04-15 AU AU2003222814A patent/AU2003222814B2/en not_active Expired
- 2003-04-23 PA PA20038571901A patent/PA8571901A1/es unknown
- 2003-04-23 US US10/421,111 patent/US20040033983A1/en not_active Abandoned
- 2003-04-23 PE PE2003000404A patent/PE20040596A1/es not_active Application Discontinuation
- 2003-04-23 TW TW092109477A patent/TW200404536A/zh unknown
- 2003-04-24 AR ARP030101425A patent/AR039664A1/es not_active Application Discontinuation
- 2003-04-24 GT GT200300094A patent/GT200300094A/es unknown
2006
- 2006-02-07 US US11/348,828 patent/US7816342B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR100625399B1 (ko)	2006-09-20
CN1325050C (zh)	2007-07-11
DE60330764D1 (de)	2010-02-11
PA8571901A1 (es)	2004-05-26
GT200300094A (es)	2004-01-15
KR20040104626A (ko)	2004-12-10
EP1501498A1 (en)	2005-02-02
US20060135471A1 (en)	2006-06-22
AU2003222814B2 (en)	2006-08-24
ES2335876T3 (es)	2010-04-06
ATE453390T1 (de)	2010-01-15
PL216022B1 (pl)	2014-02-28
US20040033983A1 (en)	2004-02-19
RU2004134573A (ru)	2005-10-10
JP4234017B2 (ja)	2009-03-04
CA2483002C (en)	2011-02-01
CN1649580A (zh)	2005-08-03
JP2005531536A (ja)	2005-10-20
TW200404536A (en)	2004-04-01
EP1501498B1 (en)	2009-12-30
BRPI0309406B1 (pt)	2017-04-11
US7816342B2 (en)	2010-10-19
CA2483002A1 (en)	2003-11-06
AU2003222814A1 (en)	2003-11-10
BR0309406A (pt)	2005-02-01
MXPA04010371A (es)	2005-02-03
PE20040596A1 (es)	2004-09-15
WO2003090742A1 (en)	2003-11-06
AR039664A1 (es)	2005-03-02
RU2297221C2 (ru)	2007-04-20

Legal Events

Date	Code	Title	Description
2014-05-30	RECP	Rectifications of patent specification

Publication	Publication Date	Title
AU2003226174A1 (en)	2003-12-02	Methods and compositions employing a dialkyl amide
EP1479666A4 (en)	2010-10-13	ESTER CONNECTION AND THEIR MEDICAL USE
KR100984939B9 (ko)	2024-07-17	발사르탄 및 ｎｅｐ 저해제를 포함하는 제약학적 조성물
AU2003304426A1 (en)	2005-03-07	Quorum sensing and biofilm formation
PL375355A1 (pl)	2005-11-28	Nowe lipazy i ich zastosowanie
PL373692A1 (pl)	2005-09-05	Kompozycja farmaceutyczna zawierająca inhibitory lipazy i glukomannan
AU2003232821A1 (en)	2003-12-02	Novel phospholipases and uses thereof
AU2003291828A1 (en)	2004-06-23	Microspheres and related processes and pharmaceutical compositions
AU2003281687A1 (en)	2004-02-16	Photopolymerizable composition and use thereof
SI1849468T1 (sl)	2013-03-29	Farmacevtski sestavek, ki obsega roflumilast in levocetirizin
IL165112A0 (en)	2005-12-18	Variant integrinpolypeptides and thereof
AUPS189402A0 (en)	2002-05-30	A drainage composition and uses thereof
AU2003262073A1 (en)	2004-04-08	Antitussives
AU2003231955A1 (en)	2003-12-19	Pharmaceutical compositions comprising abacavir and lamivudine
SI1581258T1 (sl)	2018-12-31	Farmacevtska formulacija in postopek za njeno izdelavo
AU2003231827A1 (en)	2003-12-12	Pseudo-tissues and uses thereof
AU2003302173A1 (en)	2004-07-14	Spirotetrathiocarbamates and spirooxothiocarbamates
PL352387A1 (en)	2003-08-25	Pharmaceutical composition containing sibutramine and a lipase inhibitor
AU2003267790A8 (en)	2004-04-19	Lipase inhibitors and uses thereof
AU2003226077A1 (en)	2003-11-03	Cleaning compositions in the form of a tablet
AU2003217024A1 (en)	2003-10-13	Combination comprising a cdk inhibitor and doxorubicin
AU2003258772A8 (en)	2003-12-02	Novel neutracetical and pharmaceutical compositions and their uses
GB0200877D0 (en)	2002-03-06	A lightfitting and a method of packaging the same
AU2003293857A1 (en)	2004-07-22	Carriageway surface and carriageway construction comprising a surface of this type
AU2003216442A1 (en)	2003-09-09	Enkurin and uses thereof